Amedeo Smart

Free Medical Literature Service

 

Amedeo

Alzheimer's Disease
  Free Subscription

Articles published in
Science
    June 2024
  1. PARK J, Wang J, Guan W, Gjesteby LA, et al
    Integrated platform for multiscale molecular imaging and phenotyping of the human brain.
    Science. 2024;384:eadh9979.
    >> Share

  2. COUZIN-FRANKEL J
    New Alzheimer's drug clears FDA advisory vote despite unknowns.
    Science. 2024;384:1164-1165.
    >> Share

  3. PILLER C
    Authors move to retract discredited Alzheimer's study.
    Science. 2024;384:1055.
    >> Share

    May 2024
  4. PRINCEN K, Van Dooren T, van Gorsel M, Louros N, et al
    Pharmacological modulation of septins restores calcium homeostasis and is neuroprotective in models of Alzheimer's disease.
    Science. 2024;384:eadd6260.
    >> Share

  5. TOPOL EJ
    Medical forecasting.
    Science. 2024;384:eadp7977.
    >> Share

    March 2024
  6. PILLER C
    'Damning' FDA inspection report undermines Alzheimer's drug.
    Science. 2024;383:1165-1166.
    >> Share

    December 2023
  7. GOLDE TE, Levey AI
    Immunotherapies for Alzheimer's disease.
    Science. 2023;382:1242-1244.
    >> Share

    November 2023
  8. PILLER C
    Brain games?
    Science. 2023;382:754-759.
    >> Share

    October 2023
  9. PILLER C
    Probe of Alzheimer's studies finds 'egregious misconduct'.
    Science. 2023;382:251-252.
    >> Share

    September 2023
  10. BALUSU S, Horre K, Thrupp N, Craessaerts K, et al
    MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer's disease.
    Science. 2023;381:1176-1182.
    >> Share

  11. SIRKIS DW, Yokoyama JS
    Role for cell death pathway in Alzheimer's disease.
    Science. 2023;381:1156-1157.
    >> Share

  12. AGUZZI A, Kampmann M
    Neurodegeneration enters the era of functional genomics.
    Science. 2023;381:eadk5693.
    >> Share

    August 2023
  13. COUZIN-FRANKEL J
    Side effects loom over Alzheimer's drugs.
    Science. 2023;381:466-467.
    >> Share

    July 2023
  14. ZHANG ZY, Harischandra DS, Wang R, Ghaisas S, et al
    TRIM11 protects against tauopathies and is down-regulated in Alzheimer's disease.
    Science. 2023;381:eadd6696.
    >> Share

    May 2023
  15. TRAVIS J
    Latest Alzheimer's antibody is 'not a miracle drug'.
    Science. 2023;380:571.
    >> Share

    April 2023
  16. PILLER C
    Report on trial death stokes Alzheimer's drug fears.
    Science. 2023;380:122-123.
    >> Share

  17. COUZIN-FRANKEL J
    Promising Alzheimer's therapies shrink brains.
    Science. 2023;380:19.
    >> Share

    January 2023
  18. COUZIN-FRANKEL J
    Alzheimer's drug approval gets a mixed reception.
    Science. 2023;379:126-127.
    >> Share

    December 2022
  19. COUZIN-FRANKEL J, Piller C
    Alzheimer's drug stirs excitement-and concerns.
    Science. 2022;378:1030-1031.
    >> Share

    November 2022
  20. PILLER C
    Whistleblower finds possible misconduct in his own papers.
    Science. 2022;378:694-695.
    >> Share

  21. ENDO F, Kasai A, Soto JS, Yu X, et al
    Molecular basis of astrocyte diversity and morphology across the CNS in health and disease.
    Science. 2022;378:eadc9020.
    >> Share

    September 2022
  22. HOFFMANN HM
    Boosting cognition with a hormone.
    Science. 2022;377:1042-1043.
    >> Share

    August 2022
  23. ASHE KH
    Alzheimer's target still viable but untested.
    Science. 2022;377:935.
    >> Share

  24. SELKOE D, Cummings J
    News story miscasts Alzheimer's science.
    Science. 2022;377:934-935.
    >> Share

  25. COOPER YA, Teyssier N, Drager NM, Guo Q, et al
    Functional regulatory variants implicate distinct transcriptional networks in dementia.
    Science. 2022;377:eabi8654.
    >> Share

    July 2022
  26. PILLER C
    Research backing experimental Alzheimer's drug was first target of suspicion.
    Science. 2022;377:363.
    >> Share

  27. PILLER C
    Research backing experimental Alzheimer's drug was first target of suspicion.
    Science. 2022;377:363.
    >> Share

  28. PILLER C
    Blots on a field?
    Science. 2022;377:358-363.
    >> Share

  29. ZHOU X, Sumrow L, Tashiro K, Sutherland L, et al
    Mutations linked to neurological disease enhance self-association of low-complexity protein sequences.
    Science. 2022;377:eabn5582.
    >> Share

    January 2022
  30. YANG Y, Arseni D, Zhang W, Huang M, et al
    Cryo-EM structures of amyloid-beta 42 filaments from human brains.
    Science. 2022;375:167-172.
    >> Share

    December 2021
  31. LESLIE M
    Blood condition may guard against Alzheimer's.
    Science. 2021;374:1425.
    >> Share

    October 2021
  32. SELKOE DJ
    Alzheimer's drugs: Does reducing amyloid work?-Response.
    Science. 2021;374:545-546.
    >> Share

  33. THAMBISETTY M, Howard R, Glymour MM, Schneider LS, et al
    Alzheimer's drugs: Does reducing amyloid work?
    Science. 2021;374:544-545.
    >> Share

  34. SPIRES-JONES T
    Toward a holistic model of Alzheimer'sHow Not to Study a Disease: The Story of Alzheimer's Karl Herrup MIT Press, 2021. 272 pp.
    Science. 2021;374:267.
    >> Share

    August 2021
  35. BLENNOW K
    Phenotyping Alzheimer's disease with blood tests.
    Science. 2021;373:626-628.
    >> Share

  36. SELKOE DJ
    Treatments for Alzheimer's disease emerge.
    Science. 2021;373:624-626.
    >> Share

    July 2021
  37. SERVICK K
    Alzheimer's drug approval spotlights blood tests.
    Science. 2021;373:373-374.
    >> Share

    June 2021
  38. SERVICK K
    Alzheimer's drug approved despite murky results.
    Science. 2021;372:1141.
    >> Share

    December 2020
  39. NAKAMURA T, Oh CK, Liao L, Zhang X, et al
    Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer's disease.
    Science. 2020 Dec 3. pii: science.aaw0843. doi: 10.1126/science.aaw0843.
    >> Share

    November 2020
  40. DARWICH NF, Phan JM, Kim B, Suh E, et al
    Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau.
    Science. 2020;370.
    >> Share

    October 2020
  41. BARTELS T, De Schepper S, Hong S
    Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases.
    Science. 2020;370:66-69.
    >> Share

  42. SIERKSMA A, Escott-Price V, De Strooper B
    Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets.
    Science. 2020;370:61-66.
    >> Share

  43. NEDERGAARD M, Goldman SA
    Glymphatic failure as a final common pathway to dementia.
    Science. 2020;370:50-56.
    >> Share

    August 2020
  44. SUZUKI K, Elegheert J, Song I, Sasakura H, et al
    A synthetic synaptic organizer protein restores glutamatergic neuronal circuits.
    Science. 2020;369.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016